Development and molecular characterization of a 2′, 2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
VWTR Van Haperen, G Veerman, S Eriksson, E Boven… - Cancer research, 1994 - AACR
Abstract 2′, 2′-Difluorodeoxycytidine (gemcitabine, dFdCyd) is a deoxycytidine analogue
with promising antitumor activity. In order to be active it must be phosphorylated by …
with promising antitumor activity. In order to be active it must be phosphorylated by …
[引用][C] Development and molecular characterization of a 2', 2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
VWT RUIZ VAN HAPEREN… - Cancer research …, 1994 - pascal-francis.inist.fr
Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant
variant of the human ovarian carcinoma cell line A2780 CNRS Inist Pascal-Francis CNRS …
variant of the human ovarian carcinoma cell line A2780 CNRS Inist Pascal-Francis CNRS …
[引用][C] Development and molecular characterization of a 2', 2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
R van Haperen - Cancer Res, 1994 - cir.nii.ac.jp
Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant
variant of the human ovarian carcinoma cell line A2780 | CiNii Research CiNii 国立情報学 …
variant of the human ovarian carcinoma cell line A2780 | CiNii Research CiNii 国立情報学 …
Development and molecular characterization of a 2', 2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
VWR van Haperen, G Veerman… - Cancer …, 1994 - pubmed.ncbi.nlm.nih.gov
2', 2'-Difluorodeoxycytidine (gemcitabine, dFdCyd) is a deoxycytidine analogue with
promising antitumor activity. In order to be active it must be phosphorylated by deoxycytidine …
promising antitumor activity. In order to be active it must be phosphorylated by deoxycytidine …
Development and molecular characterization of a 2′, 2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
VWTR Van Haperen, G Veerman… - Cancer …, 1994 - pure.johnshopkins.edu
Abstract 2′, 2′-Difluorodeoxycytidine (gemcitabine, dFdCyd) is a deoxycytidine analogue
with promising antitumor activity. In order to be active it must be phosphorylated by …
with promising antitumor activity. In order to be active it must be phosphorylated by …
Development and molecular characterization of a 2', 2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.
VW Ruiz van Haperen, G Veerman, S Eriksson… - Cancer …, 1994 - europepmc.org
2', 2'-Difluorodeoxycytidine (gemcitabine, dFdCyd) is a deoxycytidine analogue with
promising antitumor activity. In order to be active it must be phosphorylated by deoxycytidine …
promising antitumor activity. In order to be active it must be phosphorylated by deoxycytidine …
[引用][C] Development and molecular characterization of a 2′, 2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780
R van Haperen - Cancer Res., 1994 - cir.nii.ac.jp
Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant
variant of the human ovarian carcinoma cell line A2780 | CiNii Research CiNii 国立情報学 …
variant of the human ovarian carcinoma cell line A2780 | CiNii Research CiNii 国立情報学 …